Preventing overtreatment of breast cancer precursors
Since the introduction of screening strategies, the incidence of
Ductal Carcinoma In Situ (DCIS) has increased manifold, without a
decrease in the incidence of advanced stages of breast cancer. This
suggests that many DCIS lesions are detected that would have never
caused any clinical symptoms if screening would have been omitted.
This so-called overdiagnosis results in overtreatment, as we cannot
distinguish yet which DCIS lesions are harmless and which ones
potentially hazardous. As a consequence, many women with DCIS
lesions carry the burden of ineffective, needless treatment.
To conquer this, pathologists should try to find and validate
features that improve our risk stratification for each individual
woman with DCIS.
This international 'Dutch Breast Pathology Course' aims to
explore our possibilities, challenges, and limitations in
diagnosing and classifying breast cancer precursor lesions in the
clinical context. Therefore, input will and has to be provided by
different disciplines as well, i.e. epidemiology, radiology,
surgery, radiotherapy and the patient perspective.
To achieve all this, we intend to encourage you to practice,
interact, discuss, and come up with your ideas how to solve this
breast cancer precursor dilemma. We look very much forward to
embark with you on this challenging mission.
- Inspiring and clinically relevant lectures
- Informative case studies
- Challenging debates
- Lots of interaction and networking